Acetic Acid → 3-(tert-Butyloxycarbonyl)-7-(5-methyl-oxazol-2-yl)-2,3,4,5-tetrahydro-1H-3-benzazepine

HRID 33218

Reaktionsgleichung

Reaktionsgleichung von HRID 33218
[CH2:1]([NH:4][C:5]([C:7]1[CH:17]=[CH:16][C:10]2[CH2:11][CH2:12][NH:13][CH2:14][CH2:15][C:9]=2[CH:8]=1)=[O:6])[C:2]#[CH:3].[C:18]([OH:21])(=[O:20])C>C([O-])(=O)C.[Hg+2].C([O-])(=O)C>[C:7]([O:21][C:18]([N:13]1[CH2:12][CH2:11][C:10]2[CH:16]=[CH:17][C:7]([C:5]3[O:6][C:2]([CH3:3])=[CH:1][N:4]=3)=[CH:8][C:9]=2[CH2:15][CH2:14]1)=[O:20])([CH3:17])([CH3:8])[CH3:5]

Komponenten

4

Versuchsvorschrift

A mixture of 2,3,4,5-tetrahydro-1H-3-benzazepine-7-carboxylic acid prop-2-ynyl amide (3.8 g) and mercury (II) acetate (350 mg) in glacial acetic acid was heated under reflux for 1.5 h. After cooling, the solvent was removed in vacuo and the residue partitioned between EtOAc (200 ml) and saturated NaHCO3 solution (100 ml). The aqueous layer was re-extracted with EtOAc and the combined organic layers dried and evaporated in vacuo. The residue was purified using silica gel chromatography (gradient elution, hexane/EtOAc) to give the title compound (2.35 g) as a colourless oil.

Aufarbeitung

  1. temperaturewas heated
  2. temperatureunder reflux for 1.5 h
  3. temperatureAfter cooling
  4. customthe solvent was removed in vacuo
  5. customthe residue partitioned between EtOAc (200 ml) and saturated NaHCO3 solution (100 ml)
  6. extractionThe aqueous layer was re-extracted with EtOAc
  7. customthe combined organic layers dried
  8. customevaporated in vacuo
  9. customThe residue was purified
  10. washsilica gel chromatography (gradient elution, hexane/EtOAc)

Quellen und Nachweise

ORD-Eintrag
ord-ddafd4156ff14d62adea9bbedf94f845
Quelldatensatz
uspto-grants-2008_09
Patentnummer
US07429579B2

Verknüpfte Notizen

Wird geladen…